Previous Page  13 / 17 Next Page
Information
Show Menu
Previous Page 13 / 17 Next Page
Page Background

Pachydermoperiostose

11

Literatuurlijst

1.

BeanW. Acquired palmar erythema and cutaneous vascular “spiders”. Arch Intern Med 1974;134(5):846-853.

2.

Buiting C, Njoo K.

Richtlijn informatie uitwisseling tussen Huisarts en Specialist bij verwijzing (HASP)

. 2008. Nederlands

Huisartsen Genootschap.

3.

Cooper RG, Freemont AJ, Riley M, Holt PJ, Anderson DC, Jayson MI. Bone abnormalities and severe arthritis in

pachydermoperiostosis. Ann RheumDis 1992;51:416-9.

4.

Diggle C, Carr IM, Zitt E, Wusik K, Hopkin RJ, Prada CE, et al. Common and recurrent HPGDmutations in caucasian

individuals with primary hypertrophic osteoarthropathy. Rheumatology 2010;49:1056-1062.

5.

Diggle CP, Parry DA, Logan CV, Laissue P, Rivera C, Martín Restrepo C, et al. Prostaglandin transporter mutations cause

pachydermopriostosis with myelofibrosis. Hummutat 2012; 33:1175-1181.

6.

Eijssens EC. Rapport ’Spierziekten als zeldzame ziekten in de huisartsenpraktijk’. Amsterdam. 2006.

7.

Ginsburg J. Hypertrophic pulmonary osteoarthropathy. Postgrad Med J 1963;39:639.

8.

Gomez Rodriguez N, Ibanez Ruan J, Gonzalez Perez M. Primary hypertrophic osteoarthropathy (pachydermoperiostosis).

Report of two familial cases and literature review]. Reumatol Clin 2009;5:259-263.

9.

Hendriks SA.

Generieke zorgthema Huisartsgeneeskundige zorg .

VSOP. Soest. 2014.

10. Jajic Z, Jajic I, Nemcic T. Primary hypertrophic osteoarthropathy: clinical, radiologic and scintigraphic characteristics. Arch

med res 2001;32:136-142.

11. Kennedy CR, Xiong H, Rahal S, Vanderluit J, Slack RS, Zhang Y, et al. Urine concentrating defect in prostaglandin EP1-

deficient mice. Am J Physiol 2007;292:F868-875.

12. Khan MH, Li Z, Wang JH. Repeated exposure of tendon to prostaglandin-E2 leads to localized tendon denegration. Clin J

Sport Med 2005;15:27-33.

13. Kumar S, Sidhu S, Bhushan Mahajan B. Touraine-Soulente-Golé syndrome: a rare case report and review of the literature.

Ann Dermatol 2013;25(3):352-355.

14. Matucci-Cerinic M, Ceruso M, Lotti T, Pignone A, Jajic I. The medical and surgical treatment of finger clubbing and

hypertrophic osteoarthropathy. A blind study with colchicine and a surgical approach to finger clubbing reduction. Clin

Exp Rheumatol 1992; 10 Suppl 7:67-70.

15. Matucci-Cerinic M, Lotti T, Jajic I, Pignone A, Bussani C, Cagnoni M. The clinical spectrum of pachydermoperiostosis

(primary hypertrophic osteoarthropathy). Medicine (Baltimore) 1991;70:208-214.

16. Seyhan S, Frerichs O, Raute-Kreinsen U, Fansa H. Correction of finger clubbing in primary hypertrophic osteoarthropathy

(Touraine-Solente-Gole syndrome). Handchir Mikrochir Plas Chir 2007;39:135-8.

17. Zhang Z, XiaW, He J, Zhang Z, Ke Y, Yue H, et al. Exome sequencing identifies SLCO2A1 mutations as a cause of primary

hypertrophic osteoarthropathy. Am J HumGenet 2012; 90:125-132.

18. Zhang Z, Zhang C, Zhang Z. Primary hypertrophic osteoarthropathy: an update. Front Med 2013;7(1):60-64.